Functionalized nano-graphene-and graphene-based nanocomposites have gained tremendous attention in the area of biomedicine in recent years owing to their biocompatibility, the ease with which they can be functionalized and their properties such as thermal and electrical conductivity. potential applications for functionalized nanoparticles range from drug delivery and multimodal imaging to exploitation of the electrical properties of graphene toward the preparation of biosensing devices. this protocol covers the preparation, functionalization and bioconjugation of various graphene derivatives and nanocomposites. starting from graphite, the preparations of graphene oxide (Go), reduced Go (rGo) and magnetic Go-based nanocomposite, as well as how to functionalize them with biocompatible polymers such as polyethylene glycol (peG), are described in detail. We also provide procedures for 125 I radiolabeling of peGylated Go and the preparation of Go-based gene carriers; other bioconjugation approaches including drug loading, antibody conjugation and fluorescent labeling are similar to those described previously and used for bioconjugation of peGylated carbon nanotubes. We hope this article will help researchers in this field to fabricate graphene-based bioconjugates with high reproducibility for various applications in biomedicine. the sample preparation procedures take various times ranging from 1 to 2 d.
IntroDuctIon
In recent years, functionalized nano-graphene-and graphenebased nanocomposites have attracted attention in biomedical applications because of their unique and highly enriched physical and chemical properties [1] [2] [3] [4] [5] [6] [7] . GO and RGO can be functionalized by biocompatible polymers such as PEG, by either covalent conjugation or noncovalent surface coating, to acquire improved stability in physiological environments 8, 9 . Numerous graphenebased biosensing platforms have been reported in the past few years to detect different biological molecules on the basis of various mechanisms [10] [11] [12] . Graphene-coated substrate or graphenecontaining composite materials have also shown promise in a number of tissue engineering applications, such as enhancing the growth and differentiation of human mesenchymal stem cells 13, 14 and promoting neuronal differentiation of human neural stem cells 15 . Graphene-based devices can also be used as a sensitive platform for interfacing with biological cells to detect the change in the electrical potential of cell membrane 16, 17 . Owing to their ultra-high surface area (single sheets of carbon atoms), functionalized nanoscale GO or RGO bioconjugates have been widely explored as drug and gene carriers [18] [19] [20] [21] [22] [23] . Because of their high near-IR (NIR) absorbance, functionalized graphene derivatives can be used as photothermal agents for cancer photothermal therapy, and they have shown excellent tumor ablation therapeutic effects in a number of animal studies 8, 24, 25 . Targeting ligands such as an antibody or peptide can be conjugated to functionalized nano-graphene for targeted drug delivery 23, 26, 27 , specific cell labeling, 19 and in vivo tumor positron emission tomography (PET) imaging [28] [29] [30] . In addition, inorganic nanoparticles, such as magnetic iron oxide nanoparticles (IONPs), can be grown on the surface of GO, obtaining functional graphene-based nanocomposites (GO-IONPs) with interesting optical and magnetic properties that can be useful for multimodal imaging and imaging-guided cancer therapy 24, 31 . Moreover, we and others have shown that well-functionalized graphene derivatives are nontoxic in vitro to cells [13] [14] [15] 32 and in vivo to mice via i.v. injection, oral feeding and i.p. injection at the tested doses 2, [33] [34] [35] (Supplementary Table 1) .
Despite the explosion of interest in the development of graphene-based materials for a wide range of biomedical applications, the descriptions of methods to prepare those materials vary substantially from article to article, resulting in substantial confusion for newcomers. For example, the detailed procedures used to synthesize GO can be inconsistent in the literature 36, 37 . There are also a number of different methods for preparing RGO by reducing GO with various chemical reagents (e.g., hydroxylamine hydrochloride, formaldehyde, vitamin C, sodium borohydrate, sodium hydrosulfite and hydrazine hydrate) 25, [38] [39] [40] [41] [42] . Although those samples have the same names (GO or RGO), their sizes and properties may have large variations. A detailed protocol to describe how precisely those interesting graphene-based bioconjugates are made is therefore highly desired.
In the past few years, our group has made major efforts to explore the biomedical applications of graphene, particularly as a potential cancer theranostic agent. In this article, we will systematically summarize the procedures used in our laboratory to make functionalized nano-graphene bioconjugates for various biomedical applications 1, 8, 24, 28 .
The preparation of various GO derivatives and their surface functionalization, particularly PEG coating, is the main focus of this protocol. This protocol could be particularly helpful to researchers working or interested in the field of graphene bio-research or nanomedicine in general. The major goal of this article is to provide standard and reliable protocols to guide researchers in this field toward fabricating graphene-based bioconjugates with high reproducibility, which is often lacking in nano-biotechnology.
Step 1 covers the preparation of GO and its derivatives, and their quality control is described in Step 2.
Step 3 covers the Preparation of RGO and nRGO with different sizes. GO with abundant oxygen-containing groups on its surface can be reduced by various reducing chemicals to obtain RGO. Compared with GO, RGO shows a much lower oxygen content with the majority of oxygen-containing groups such as carboxyl, hydroxyl and ketone moieties removed during the reduction process and thus usually has a poor water solubility. However, RGO with largely restored aromatic structure shows markedly enhanced absorbance in the NIR region and is a powerful agent in photothermal therapy of cancer 25, 45 . Refluxing GO in hydrazine hydrate is one of the most commonly used approaches to prepare RGO. This is described in Step 1C. In order to obtain nanoscale RGO, or nRGO, with ultra-small sheet sizes (<50 nm), nGO-PEG can be used to replace GO as the starting material 25, 45 . In this process, the coating PEG polymer would be removed and the resulting nRGO sample would become water insoluble. This process is also described in Step 1C.
Preparation of magnetic GO nanocomposites. Magnetic GObased nanocomposites can be prepared by a hydrothermal growth method starting from GO. In this process, with sodium acrylate and sodium acetate acting as the reducing agents, FeCl 3 is hydrolyzed and reduced to form Fe 3 O 4 IONPs attached on the surface of GO. Notably, GO can also be partially reduced during this reaction, yielding RGO-IONPs with strong superparamagnetism 24, 31 . This procedure is described in Step 1E.
Noncovalent functionalization of RGO, nRGO and RGO-IONP.
RGO, nRGO and RGO-IONP with limited numbers of available −COOH groups can be noncovalently functionalized by sonication in solutions of amphiphilic polymers such as our home-made C18PMH-PEG or commercially available phospholipid-PEG 25, 45 . The hydrophobic chains of C18PMH-PEG are strongly anchored onto the RGO surface, whereas the hydrophilic PEG chains offer those materials great water solubility and excellent stability in various biological solutions. It is worth noting that RGO-PEG prepared by sonicating RGO in the C18PMH-PEG solution would show much larger sheet sizes (atomic force microscopy (AFM)-measured average diameter ~67 nm) compared with nGO-PEG with covalent PEG coating (AFM-measured average diameter ~23 nm). Therefore, to obtain ultra-small PEGylated RGO (nRGO-PEG), a reliable approach is to reduce nGO-PEG to make nRGO, which is then sonicated in C18PMH-PEG to yield nRGO-PEG with similarly ultra-small sizes (AFM-measured average diameter ~25 nm) as that of nGO-PEG 25, 45 . The PEG coating density of RGO-PEG and nRGO-PEG, however, is thicker than that of nGO-PEG, as evidenced by the increased sheet thickness revealed by AFM, as well as the remarkably prolonged blood circulation half-life of the former after i.v. injection. The concentrations of RGO and nRGO are determined by their UV-visible absorption at 270 nm with a weight extinction coefficient of 70 mg ml −1 cm −1 . This process is described in Steps 1D and 1F.
Compared with other reported methods for preparing functionalized GO derivatives, our approach based on PEGylation offers a number of different advantages 8, 25, 33 : (i) compared with GO without surface coating, the PEGylation derivatives have much lower lung uptake and show remarkably reduced toxicity in vitro and in vivo; (ii) the use of amine-terminated branched PEG to functionalize GO allows us to use the amino groups for further conjugation of antibody, peptide, fluorescence dye and radiolabeling linker; and (iii) compared with other polymers such as amine-modified dextran or chitosan 9, 46 , PEG has a defined structure and molecular weight. However, successful PEGylation requires careful controlling of the preparation procedures (e.g., appropriate treating of GO with base, adding the right amount of catalyst during reaction and so on) and thus needs a detailed protocol as a guideline.
Step 2: quality control steps It is important to check the quality of functionalized graphene derivatives on the basis of various characterization approaches, such as stability in saline solution ( Step 2A), UV-visible-NIR spectra ( Step 2B) and AFM images (Step 2C).
RGO and nRGO usually have limited water solubility. GO and RGO-IONP, although soluble in water, are not stable in the presence of salts. Therefore, the most straightforward method to determine whether PEGylation is successful or not is to test the stability of PEGylated samples in saline. Generally speaking, we usually add the PEGylated samples into solutions containing 9% (wt/vol) sodium chloride, which is 10× physiological saline, and then centrifuge the samples to check their saline stability. GO derivatives with acceptable PEG coating show few precipitates under such conditions. UV-visible NIR spectra of various GO derivatives should also be recorded in the quality check step. The UV/NIR absorbance ratios of various samples calculated by the UV peak absorbance (~230 nm for GO and nGO-PEG, ~270 nm for RGO-PEG and nRGO-PEG) versus their NIR absorbance at 800 nm are important in order to determine whether the samples have been correctly prepared or not (e.g., with sufficient reduction for RGO samples). We also use the UV absorbance peaks of those samples to determine the concentrations.
Finally, AFM imaging of various GO derivatives can be carried out to determine the sizes and thicknesses of various samples. Compared with other nanoscale imaging techniques such as transmission electron microscopy (TEM) and scanning electron microscopy (SEM), AFM is probably the most convenient method to characterize the morphology of this type of 2D nanomaterial, as AFM shows a much higher resolution compared with SEM and offers better contrast compared with TEM.
Step 3: preparation of GO-based bioconjugates 125 I labeling of nGO-PEG, nRGO-PEG and RGO-PEG. 125 I labeling as a relatively accurate method to track the in vivo behaviors of GO and its derivatives has been intensively used in our group. The half-life of 125 I is ~60 d, which is much longer than many other isotopes used for nanomaterial labeling, such as 64 Cu (t 1/2 = 12.7 h), thereby allowing us to track the in vivo behaviors of PEGylated GO over a much longer period of time. In contrast, 125 I can be easily labeled to the defect sites of PEGylated GO without a need to use the functional groups on PEG. However, on the basis of our observation, although 125 I labeling on PEGylated GO is quite stable, 125 I labeled on uncoated GO could gradually detach from GO in physiological solutions, likely due to the instability of GO in the presence of salts and proteins. We compared the biodistribution of free 125 I with that of 125 I-labeled nGO-PEG in our previous study 33 and found that free 125 I was rapidly excreted within 6 h of i.v. injection (Supplementary Fig. 1) .
Labeling of PEGylated GO with radioactive iodine happens on the defect sides of the GO sheets (e.g., on the edges or within the GO sheet with dangling bonds and broken six-member rings) by an electrophilic addition reaction, and thus it does not require the amino groups on the PEG coating. Different PEGylated GO derivatives including nGO-PEG, nRGO-PEG, RGO-PEG and even RGO-IONP-PEG can all be labeled by 125 I using a standard chloramine-T oxidation method (Step 3A).
Use of nGO-PEG-PEI for transfection. In our and others' previous work, polyethyleneimine (PEI)-functionalized GO (GO-PEI) complexes prepared via either the electrostatic interaction between GO sheets and PEI or the covalent conjugation between carboxyl groups of GO and amino groups of PEI have been found to be effective for in vitro plasmid DNA and siRNA delivery 20, 47 . However, we discovered that GO-PEI would aggregate in serum-containing environment, resulting in markedly decreased transfection efficiency when cells were transfected in the presence of serum. Inspired by the well-known serum stealth effect of PEG, we fabricated a dualpolymer-coated gene delivery carrier, nGO-PEG-PEI. Compared with GO-PEI, nGO-PEG-PEI exhibited superior physiological stability, reduced cytotoxicity and remarkably improved gene transfection efficiency without serum interference (Step 3B) 21 .
MaterIals

REAGENTS
Preparation of GO and its derivatives
Graphite Cyclone storage phosphor screen system (PerkinElmer, C431200) REAGENT SETUP Ultrapure water Prepare ultrapure water by purifying deionized (DI) water using the Easypure RoDi system (Thermo) according to the standard protocol. The ultrapure water can be stored in autoclaved clean glass vials at room temperature (25 °C) for 1 month if appropriately sealed. C18PMH-PEG synthesis Prepare C18PMH-PEG according to a previously reported protocol 48 . In brief, weigh 143 mg of mPEG-NH 2 (5k) and 10 mg of poly(maleic anhydride-alt-1-octadecene) into a 25-ml glass vial, and add 2 ml of dichloromethane containing triethylamine (200 µl). Allow the reaction to proceed at room temperature under magnetic stirring with the glass vial tightly sealed. Afterward, dry the solvent under a nitrogen stream. Dissolve the yielded solid product in 5 ml of water. Dialyze the solution against water (1 liter) using a 14-kDa MWCO membrane for 1 d to remove the excess mPEG-NH 2 , and then lyophilize the solution. The solid powder is the product of C18PMH-PEG, which can be stored at −20 °C for 6 months. Phosphate buffer, 1× PB, pH 7.5 Dissolve 6.04 g of Na 2 HPO 4 ·12H 2 O and 1.56 g of NaH 2 PO 4 ·12H 2 O in 100 ml of ultrapure water. It can be stored at room temperature for 1 month. EGFP plasmid Dissolve 50 µg of EGFP plasmid in 100 µl of Tris-EDTA (10 mM, pH 8.0) buffer at a concentration of 500 ng µl −1 before use. The dissolved mixture can be stored at −20 °C for 6 months. Avoid repeated freeze-thaw cycles. Cell culture Culture HeLa cells in DMEM (high glucose) supplemented with 10% (vol/vol) FBS and 1% (vol/vol) penicillin-streptomycin at 37 °C in a humidified atmosphere containing 5% CO 2 . For transfection experiments, seed 8 × 10 4 cells in 500 µl of DMEM medium into each well of the 24-well plate, and incubate the plate at 37 °C for 24 h to ensure each well has reached ~70% confluency before transfection. Animals Healthy female BALB/c mice ages between 6 and 8 weeks, which are one of the most commonly used inbred strains, are used in our experiments. ! cautIon Make sure to undergo appropriate training regarding animal handling and have animal protocols in place before performing animal studies. EQUIPMENT SETUP Atomic force microscope AFM characterization is performed using a Veeco NanoScope IV AFM instrument. Standard silicon cantilevers purchased from Olympus (cat. no. OMCL-AC160TS-R3) are used as the AFM tip during imaging. Confocal laser-scanning microscope The confocal imaging experiment is conducted using a Leica SP5 confocal laser-scanning microscopy (CLSM) instrument. EGFP-transfected HeLa cells cultured in 35-mm culture dishes are imaged by CLSM under the ×10 objective with an excitation of 488 nm and an emission band between 500 and 600 nm. proceDure preparation of Go and its derivatives 1| The first step is to prepare GO derivatives with different surface chemistry and sizes (table 1) for varied aims of applications (Fig. 1) . The options include preparation of GO (Step 1A), nGO-PEG (Step 1B), RGO or nRGO (Step 1C), RGO-PEG or nRGO-PEG (Step 1D), RGO-IONP (Step 1E) and RGO-IONP-PEG (Step 1F). (a) preparation of Go • tIMInG 2 d (i) Mix 1g of graphite powder with 60 g of NaCl in a glass beaker. Grind this mixture in a mortar until a gray powder is formed. NaCl is added to increase the efficiency during grinding. ! cautIon When you are grinding, wear a lab coat and a face mask to avoid inhalation of the powder. (ii) Suspend the powder in 1 liter of water (the NaCl will dissolve), and remove the dissolved NaCl by filtration. Put the filter paper containing graphite powder into oven and heat at 90 °C overnight to remove the water. ! cautIon Please ensure that the temperature of the oven is accurately controlled. Approximately 20% of the graphite will be lost during this step owing to grinding and washing. ! cautIon Keep the temperature precisely at 40 ± 2 °C. If the reaction temperature is too high or too low, the quality of GO may be affected. (vi) Heat the mixture to 70 °C for 45 min. After heating for 15 min, the color of the mixture should change to a dark brown slurry.
? troublesHootInG (vii) Add 3 ml of DI water into the three-necked flask. Heat the mixture to 105 °C for 5 min. Add another 3 ml of DI water into the mixture with the temperature kept at 105 °C for 5 min. Thereafter, add another 40 ml of DI water with the temperature maintained at 100 °C for 15 min.  crItIcal step Water should be added slowly. Make sure that the temperature is kept below 108 °C. If water is added too fast, the temperature of the reaction may be quickly increased to over 110 °C. (viii) Terminate the reaction by adding DI water (140 ml) and 30% (vol/vol) H 2 O 2 solution (10 ml).
! cautIon H 2 O 2 is a dangerous chemical. Wear a lab coat, gloves and goggles during experiments. (ix) Centrifuge the product at 9,000g for 5 min at room temperature. Discard the supernatant and wash the precipitated solid twice using 5% (vol/vol) HCl; next, wash three times with DI water. 
RGO-IONP RGO-IONP-PEG
Steps 1A and 1B
Step 1C
Step 1D
Step 1E
Step 1E (x) Re-disperse and store the final GO product in DI water at room temperature. The concentration of GO solution can be determined by its UV-visible NIR absorbance spectrum with a weight extinction coefficient of 47.6 mg ml −1 cm −1 at 230 nm.
? troublesHootInG  pause poInt The GO can be stored at room temperature for 6 months without obvious changes in properties.
(b) preparation of nGo-peG • tIMInG 1-2 d
(i) Add 1.8 g of NaOH into 10 ml of GO solution at the concentration of 10 mg ml −1 (the final product of Step 1A).
Heat the mixture at 55 °C for 4 h. ! cautIon NaOH is highly corrosive. Wear lab coat, gloves and goggles during experiments. (ii) Add 37% (vol/vol) HCl solution (6-7 ml) into the solution to neutralize NaOH. Wash the product four times with DI water to remove the salt. Collect the product (base-treated GO) during washing by centrifugation at 9,000g for 5 min. ! cautIon HCl is highly corrosive. Wear lab coat, gloves and goggles during experiments. (i) Add 1 ml of hydrazine hydrate into 10 ml of GO solution at the concentration of 10 mg ml −1 (the final product of
Step 1A), or 10 ml of nGO-PEG solution at the concentration of 2 mg ml −1 (the final product of Step 1B), in a 50-ml round-bottomed flask. Reflux the solution at 95 °C for 24 h under stirring. (ii) After cooling down the above solution to room temperature, use a vacuum filtration device to remove hydrazine hydrate through a 100-nm filter membrane. Wash the solid retained in the filtration device four or five times using DI water, yielding RGO or nRGO product in black solid.  pause poInt The as-made RGO or nRGO can be stored at room temperature for 6 months without obvious changes in properties.  crItIcal step The GO sample used here should have a very high concentration (~10 mg ml −1 ) to minimize the amount of water introduced into the reaction system. (ii) Transfer the mixture to a Teflon-lined stainless steel autoclave and heat it at 200 °C for 10 h in an oven.
! cautIon Make sure the autoclave is tightly sealed before the mixture is transferred into the oven. This experiment should be carried out in a separate room without other people working around. ! cautIon Select a suitable centrifugal speed to remove the aggregates without losing much product. A higher centrifugation speed may lead to a much lower yield. (iv) Collect the supernatant, and filter it through a 100-nm filter membrane using a vacuum filtration device. Wash the product three times with DI water to remove excess C18PMH-PEG. (v) Re-disperse the product retained in the filtration device in DI water. Store the obtained RGO-IONP-PEG at 4 °C.
 pause poInt The obtained RGO-IONP-PEG may be stored at 4 °C for ~2 months without obvious changes in stability and other properties.
Quality control steps • tIMInG 1 d 2| Before using various PEGylated GO derivatives for further bioconjugation, it is important to ensure that they are of sufficient quality. Possible quality control tests include the saline stability test (option A), analysis by UV-visible-NIR (option B) and AFM (option C). Because the GO and RGO-IONP, as well as other samples with failed surface functionalization, would rapidly aggregate in the presence of salts owing to the electron-screening effect, we usually use the saline stability test as a convenient quality check approach to determine whether the PEG functionalization is successful or not. (ii) Treat the silicon substrate with APTES (12 µl in 10 ml of water) for 15 min, and wash it with acetone, methanol and isopropanol. (iii) Drop the solution of GO, nGO-PEG, RGO-PEG, nRGO-PEG or RGO-IONP-PEG with a concentration of ~0.05 mg ml −1 onto the surface of silicon substrate. After 10 min, wash the substrate with DI water and dry it by blowing nitrogen. (iv) Use AFM to image the various GO derivatives deposited on the silicon substrate. preparation of Go-based bioconjugates 3| To realize specific biomedical applications, functionalized GO derivatives prepared in Step 1 can be further modified with various different approaches, as illustrated in Figure 2 . However, as many of those procedures are quite similar to the bioconjugation of PEGylated SWNTs as described in detail in our previously published protocol, we will only focus on option 3A ( 125 I labeling) and option 3B (preparation of GO-based gene carriers), which were not included in the earlier paper 43 . Although option 3A is generally applicable to all PEGylated GO derivatives including nGO-PEG, GO-IONP-PEG, nRGO-PEG, RGO-PEG and RGO-IONP-PEG, option 3B, which includes the preparation of the gene delivery system, uses GO as the starting material. Step 1B
Refer to options A and B in ref. 44 Step Step 3A is 125 I labeling of nGO-PEG, and
Step 3B is the preparation of nGO-PEG-PEI and the subsequent complexing with pDNA for gene transfection. The procedures for antibody conjugation, 64 Cu labeling and drug loading to PEGylated nano-GO can be found in the preparation of corresponding bioconjugates based on PEGylated SWNTs, as described in detail in ref. 44. (ii) Purify the solution through an Amicon centrifugal filter device (MWCO = 100 kDa), and wash it four or five times with DI water to remove excess 125 I. A radiolabeling yield of 50% is usually achieved. ! cautIon Radioisotope waste, including contaminated devices such as filters, should be collected and disposed of in designated containers shielded with lead. ? troublesHootInG Troubleshooting advice can found in table 2
• tIMInG
Step 1A, preparation of GO: 2 d
Step 1B, preparation of nGO-PEG: 1-2 d
Step 1C, preparation of RGO and nRGO: 1-2 d
Step 1D, preparation of RGO-PEG and nRGO-PEG: 1-2 d
Step 1E, synthesis of RGO-IONP composite: 2 d
Step 1F, preparation of RGO-IONP-PEG: 1 d
Step 2A, saline stability test: 1 h
Step 2B, UV-visible NIR absorbance spectra: 1 h
Step 2C, AFM characterization: 2 h
Step 3A, 125 I labeling of nGO-PEG, nRGO-PEG and RGO-PEG: 1 d
Step 3B, preparation of GO-based gene carriers (nGO-PEG-PEI): 1-2 d
antIcIpateD results
Functionalization of Go and its derivatives
All GO derivatives prepared in Step 1 are water soluble, except RGO and nRGO before PEGylation, which have limited water solubility. GO and RGO-IONPs are water soluble but would precipitate in the presence of salts. In contrast, PEGylated GO derivatives including nGO-PEG, RGO-PEG, nRGO-PEG and RGO-IONP-PEG are all highly stable in various biological solutions including saline and serum (Fig. 3a) . Although GO and nGO-PEG show the UV-visible absorbance peak at ~230 nm, the absorbance peaks of RGO-PEG and nRGO-PEG are located at ~270 nm (Fig. 3b) .
Compared with GO and nGO-PEG, RGO-PEG, nRGO-PEG and RGO-IONP-PEG exhibit greatly enhanced NIR absorbance (Fig. 3b,c) .
AFM is used to determine the sizes of GO derivatives (Fig. 3d) . The size of GO before PEGylation has a wide distribution around 100-500 nm, whereas nGO-PEG sheets after PEGylation are much smaller with an average size of ~23 nm. The average sizes of RGO-PEG and nRGO-PEG are ~65 and ~27 nm, respectively. With covalent functionalization, the sheet thickness of nGO-PEG is 1-2 nm; in contrast, the sheet thickness of RGO-PEG and nRGO-PEG with noncovalent functionalization is increased to ~4-6 nm due to polymer (C18PMH-PEG) coating on RGO or nRGO surface 23 . Similarly to GO and nGO-PEG, the average size of PEGylated RGO-IONP became much smaller (~67 nm) than RGO-IONP (~202 nm) 22 (Fig. 3d) .
I-labeled nGo-peG for long-term biodistribution studies
In this labeling method, 125 I atoms are anchored on the defect sites or edges of the GO sheet (Fig. 4a) . The obtained 125 I-nGO-PEG would show great radiolabeling stability without marked detachment of labeled 125 I in saline, serum and plasma under 37 °C within 2 weeks (Fig. 4b) . BALB/c mice i.v. injected with 125 I-nGO-PEG are killed at different time points after being injected. Biodistribution data based on radioactivity measurement reveal that nGO-PEG would mainly 29 and can be gradually flushed out from the mouse body over time 31 (Fig. 4c) .
Go-based gene transfection
Prepared nGO-PEG-PEI with an ultrasmall size (Fig. 5a ) shows excellent stability in physiological solutions (Fig. 5b) , as well as lower cytotoxicity, when compared with bare PEI polymer (Fig. 5c) . nGO-PEG-PEI shows high EGFP pDNA transfection efficiency, which is not markedly affected by adding FBS during transfection. In contrast, although satisfied transfection efficiencies of bare PEI polymer and GO-PEI can be achieved in FBS-free medium, the existence of serum would lead to substantially decreased transfection efficiencies when these two are used as the pDNA transfection agents 19 (Fig. 5d,e) . 
